Neratinib could be effective as monotherapy or in combination with trastuzumab in HER2-low breast cancer cells and organoid models
Arshad, Maryam, Azad, Abul, Chan, Phoebe Yuen Ka, Vigneswara, Vasanthy, Feldinger, Katharina, Nafi, Siti Norasikin Mohd, Laporte-Maguire, Eloise, De Santo, Carmela, Zuo, Jianmin, Shaaban, Abeer M., Kong, Anthony
Published in British journal of cancer (01.06.2024)
Published in British journal of cancer (01.06.2024)
Get full text
Journal Article